BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220120T110000
DTEND;TZID=America/Vancouver:20220120T120000
DTSTAMP:20260619T101556
CREATED:20211217T202505Z
LAST-MODIFIED:20211217T202505Z
UID:32642-1642676400-1642680000@scienceinvancouver.com
SUMMARY:AI in Med Lecture: Dr. Anne Martel
DESCRIPTION:SBME x BMIAI x the BC Translational Digital Pathology Initiative are proud to co-present a special lecture:\n“Artificial Intelligence and digital pathology: dealing with the annotation bottleneck”\nABSTRACT \nThe introduction of scanners that are capable of digitizing microscopic slides at high magnification has led to an explosion of interest in computational pathology in general and deep learning applied to whole slide images (WSIs) in particular. In my lab at Sunnybrook\, we are developing AI models that can detect cancer\, automatically segment regions of interest\, and learn predictive and prognostic models that can be used to guide treatment decisions. In this talk I will outline some of the unique challenges of working with these extremely large WSIs and discuss some of the approaches that we have developed to overcome the problems of sparse annotations and weak\, noisy labels\, including self-supervision and multiple instance learning. I will also outline some of the challenges in deploying AI algorithms to the clinic.
URL:https://scienceinvancouver.com/event/ai-in-med-lecture-dr-anne-martel-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Seminar-Poster-2022.01.20-Anne-Martel-Med-in-AI-2048x1152-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220120T110000
DTEND;TZID=America/Vancouver:20220120T120000
DTSTAMP:20260619T101556
CREATED:20211217T202505Z
LAST-MODIFIED:20211217T202505Z
UID:19884-1642676400-1642680000@scienceinvancouver.com
SUMMARY:AI in Med Lecture: Dr. Anne Martel
DESCRIPTION:SBME x BMIAI x the BC Translational Digital Pathology Initiative are proud to co-present a special lecture:\n“Artificial Intelligence and digital pathology: dealing with the annotation bottleneck”\nABSTRACT \nThe introduction of scanners that are capable of digitizing microscopic slides at high magnification has led to an explosion of interest in computational pathology in general and deep learning applied to whole slide images (WSIs) in particular. In my lab at Sunnybrook\, we are developing AI models that can detect cancer\, automatically segment regions of interest\, and learn predictive and prognostic models that can be used to guide treatment decisions. In this talk I will outline some of the unique challenges of working with these extremely large WSIs and discuss some of the approaches that we have developed to overcome the problems of sparse annotations and weak\, noisy labels\, including self-supervision and multiple instance learning. I will also outline some of the challenges in deploying AI algorithms to the clinic.
URL:https://scienceinvancouver.com/event/ai-in-med-lecture-dr-anne-martel/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Seminar-Poster-2022.01.20-Anne-Martel-Med-in-AI-2048x1152-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220120T110000
DTEND;TZID=America/Vancouver:20220120T120000
DTSTAMP:20260619T101556
CREATED:20211217T202505Z
LAST-MODIFIED:20211217T202505Z
UID:26484-1642676400-1642680000@scienceinvancouver.com
SUMMARY:AI in Med Lecture: Dr. Anne Martel
DESCRIPTION:SBME x BMIAI x the BC Translational Digital Pathology Initiative are proud to co-present a special lecture:\n“Artificial Intelligence and digital pathology: dealing with the annotation bottleneck”\nABSTRACT \nThe introduction of scanners that are capable of digitizing microscopic slides at high magnification has led to an explosion of interest in computational pathology in general and deep learning applied to whole slide images (WSIs) in particular. In my lab at Sunnybrook\, we are developing AI models that can detect cancer\, automatically segment regions of interest\, and learn predictive and prognostic models that can be used to guide treatment decisions. In this talk I will outline some of the unique challenges of working with these extremely large WSIs and discuss some of the approaches that we have developed to overcome the problems of sparse annotations and weak\, noisy labels\, including self-supervision and multiple instance learning. I will also outline some of the challenges in deploying AI algorithms to the clinic.
URL:https://scienceinvancouver.com/event/ai-in-med-lecture-dr-anne-martel-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Seminar-Poster-2022.01.20-Anne-Martel-Med-in-AI-2048x1152-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220120T110000
DTEND;TZID=America/Vancouver:20220120T120000
DTSTAMP:20260619T101556
CREATED:20211217T202505Z
LAST-MODIFIED:20211217T202505Z
UID:28099-1642676400-1642680000@scienceinvancouver.com
SUMMARY:AI in Med Lecture: Dr. Anne Martel
DESCRIPTION:SBME x BMIAI x the BC Translational Digital Pathology Initiative are proud to co-present a special lecture:\n“Artificial Intelligence and digital pathology: dealing with the annotation bottleneck”\nABSTRACT \nThe introduction of scanners that are capable of digitizing microscopic slides at high magnification has led to an explosion of interest in computational pathology in general and deep learning applied to whole slide images (WSIs) in particular. In my lab at Sunnybrook\, we are developing AI models that can detect cancer\, automatically segment regions of interest\, and learn predictive and prognostic models that can be used to guide treatment decisions. In this talk I will outline some of the unique challenges of working with these extremely large WSIs and discuss some of the approaches that we have developed to overcome the problems of sparse annotations and weak\, noisy labels\, including self-supervision and multiple instance learning. I will also outline some of the challenges in deploying AI algorithms to the clinic.
URL:https://scienceinvancouver.com/event/ai-in-med-lecture-dr-anne-martel-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Seminar-Poster-2022.01.20-Anne-Martel-Med-in-AI-2048x1152-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220120T110000
DTEND;TZID=America/Vancouver:20220120T120000
DTSTAMP:20260619T101556
CREATED:20211217T202505Z
LAST-MODIFIED:20211217T202505Z
UID:31182-1642676400-1642680000@scienceinvancouver.com
SUMMARY:AI in Med Lecture: Dr. Anne Martel
DESCRIPTION:SBME x BMIAI x the BC Translational Digital Pathology Initiative are proud to co-present a special lecture:\n“Artificial Intelligence and digital pathology: dealing with the annotation bottleneck”\nABSTRACT \nThe introduction of scanners that are capable of digitizing microscopic slides at high magnification has led to an explosion of interest in computational pathology in general and deep learning applied to whole slide images (WSIs) in particular. In my lab at Sunnybrook\, we are developing AI models that can detect cancer\, automatically segment regions of interest\, and learn predictive and prognostic models that can be used to guide treatment decisions. In this talk I will outline some of the unique challenges of working with these extremely large WSIs and discuss some of the approaches that we have developed to overcome the problems of sparse annotations and weak\, noisy labels\, including self-supervision and multiple instance learning. I will also outline some of the challenges in deploying AI algorithms to the clinic.
URL:https://scienceinvancouver.com/event/ai-in-med-lecture-dr-anne-martel-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Seminar-Poster-2022.01.20-Anne-Martel-Med-in-AI-2048x1152-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220119T153000
DTEND;TZID=America/Vancouver:20220119T163000
DTSTAMP:20260619T101556
CREATED:20220114T192310Z
LAST-MODIFIED:20220114T192310Z
UID:20250-1642606200-1642609800@scienceinvancouver.com
SUMMARY:The Natural and Sexual Selection of Endometriosis
DESCRIPTION:We have developed a new theory for the proximate and ultimate causes of endometriosis. We describe evidence from genetics\, endocrinology\, morphology\, behaviour\, and life history that risk for endometriosis is driven by low prenatal and postnatal testosterone\, and that the evolution of endometriosis risks\, symptoms and correlates have been mediated by both sexual selection and natural selection. The work: (1) shows how sexual selection can lead to maladaptive extremes of reproductive adaptations that manifest in symptoms of disease\, (2) provides an example of conceptual sex biases in physiology and medicine\, and (3) provides new insights directly relevant to endometriosis treatment. \nSpeaker: Bernard Crespi\, Simon Fraser University
URL:https://scienceinvancouver.com/event/the-natural-and-sexual-selection-of-endometriosis/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220119T153000
DTEND;TZID=America/Vancouver:20220119T163000
DTSTAMP:20260619T101556
CREATED:20220114T192310Z
LAST-MODIFIED:20220114T192310Z
UID:26497-1642606200-1642609800@scienceinvancouver.com
SUMMARY:The Natural and Sexual Selection of Endometriosis
DESCRIPTION:We have developed a new theory for the proximate and ultimate causes of endometriosis. We describe evidence from genetics\, endocrinology\, morphology\, behaviour\, and life history that risk for endometriosis is driven by low prenatal and postnatal testosterone\, and that the evolution of endometriosis risks\, symptoms and correlates have been mediated by both sexual selection and natural selection. The work: (1) shows how sexual selection can lead to maladaptive extremes of reproductive adaptations that manifest in symptoms of disease\, (2) provides an example of conceptual sex biases in physiology and medicine\, and (3) provides new insights directly relevant to endometriosis treatment. \nSpeaker: Bernard Crespi\, Simon Fraser University
URL:https://scienceinvancouver.com/event/the-natural-and-sexual-selection-of-endometriosis-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220119T153000
DTEND;TZID=America/Vancouver:20220119T163000
DTSTAMP:20260619T101556
CREATED:20220114T192310Z
LAST-MODIFIED:20220114T192310Z
UID:28112-1642606200-1642609800@scienceinvancouver.com
SUMMARY:The Natural and Sexual Selection of Endometriosis
DESCRIPTION:We have developed a new theory for the proximate and ultimate causes of endometriosis. We describe evidence from genetics\, endocrinology\, morphology\, behaviour\, and life history that risk for endometriosis is driven by low prenatal and postnatal testosterone\, and that the evolution of endometriosis risks\, symptoms and correlates have been mediated by both sexual selection and natural selection. The work: (1) shows how sexual selection can lead to maladaptive extremes of reproductive adaptations that manifest in symptoms of disease\, (2) provides an example of conceptual sex biases in physiology and medicine\, and (3) provides new insights directly relevant to endometriosis treatment. \nSpeaker: Bernard Crespi\, Simon Fraser University
URL:https://scienceinvancouver.com/event/the-natural-and-sexual-selection-of-endometriosis-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220119T153000
DTEND;TZID=America/Vancouver:20220119T163000
DTSTAMP:20260619T101556
CREATED:20220114T192310Z
LAST-MODIFIED:20220114T192310Z
UID:31195-1642606200-1642609800@scienceinvancouver.com
SUMMARY:The Natural and Sexual Selection of Endometriosis
DESCRIPTION:We have developed a new theory for the proximate and ultimate causes of endometriosis. We describe evidence from genetics\, endocrinology\, morphology\, behaviour\, and life history that risk for endometriosis is driven by low prenatal and postnatal testosterone\, and that the evolution of endometriosis risks\, symptoms and correlates have been mediated by both sexual selection and natural selection. The work: (1) shows how sexual selection can lead to maladaptive extremes of reproductive adaptations that manifest in symptoms of disease\, (2) provides an example of conceptual sex biases in physiology and medicine\, and (3) provides new insights directly relevant to endometriosis treatment. \nSpeaker: Bernard Crespi\, Simon Fraser University
URL:https://scienceinvancouver.com/event/the-natural-and-sexual-selection-of-endometriosis-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220119T153000
DTEND;TZID=America/Vancouver:20220119T163000
DTSTAMP:20260619T101556
CREATED:20220114T192310Z
LAST-MODIFIED:20220114T192310Z
UID:32655-1642606200-1642609800@scienceinvancouver.com
SUMMARY:The Natural and Sexual Selection of Endometriosis
DESCRIPTION:We have developed a new theory for the proximate and ultimate causes of endometriosis. We describe evidence from genetics\, endocrinology\, morphology\, behaviour\, and life history that risk for endometriosis is driven by low prenatal and postnatal testosterone\, and that the evolution of endometriosis risks\, symptoms and correlates have been mediated by both sexual selection and natural selection. The work: (1) shows how sexual selection can lead to maladaptive extremes of reproductive adaptations that manifest in symptoms of disease\, (2) provides an example of conceptual sex biases in physiology and medicine\, and (3) provides new insights directly relevant to endometriosis treatment. \nSpeaker: Bernard Crespi\, Simon Fraser University
URL:https://scienceinvancouver.com/event/the-natural-and-sexual-selection-of-endometriosis-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220117T120000
DTEND;TZID=America/Vancouver:20220117T130000
DTSTAMP:20260619T101556
CREATED:20211217T222024Z
LAST-MODIFIED:20211217T222024Z
UID:32647-1642420800-1642424400@scienceinvancouver.com
SUMMARY:Putting Cancer in Its Place
DESCRIPTION:DATE: Jan 17\, 2022 – 12:00pm to 1:00pm \nLOCATION: 700-828 W. 10 Ave. VGH Research Pavilion \nPRESENTER: Trevor Dummer \nCancer prevention is central to a successful cancer control strategy. Improved knowledge about cancer risks\, and effective translation of this knowledge into action\, are essential for developing prevention activities. Place—where we live\, work and play—significantly influences the accumulation of cancer risks that are modifiable through policy\, regulatory\, and behaviour changes. In this presentation I will provide an overview of my cancer prevention research program\, highlighting specific studies evaluating the interaction between people\, places\, and cancer. Attendees of this talk will gain an understanding of how the environment influences cancer risk\, and how insight into the relationship between health and place can advance cancer prevention. \nPlease contact Pamela Lee (pamela.lee@ubc.ca) for in-person or Zoom details. \n\nFILES:  C2E2 Spotlight – 011722.pdf
URL:https://scienceinvancouver.com/event/putting-cancer-in-its-place-5/
LOCATION:VGH Research Pavilion\, 828 West 10 Ave\, Vancouver\, BC\, V5Z 1M9\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220117T120000
DTEND;TZID=America/Vancouver:20220117T130000
DTSTAMP:20260619T101556
CREATED:20211217T222024Z
LAST-MODIFIED:20211217T222024Z
UID:19903-1642420800-1642424400@scienceinvancouver.com
SUMMARY:Putting Cancer in Its Place
DESCRIPTION:DATE: Jan 17\, 2022 – 12:00pm to 1:00pm \nLOCATION: 700-828 W. 10 Ave. VGH Research Pavilion \nPRESENTER: Trevor Dummer \nCancer prevention is central to a successful cancer control strategy. Improved knowledge about cancer risks\, and effective translation of this knowledge into action\, are essential for developing prevention activities. Place—where we live\, work and play—significantly influences the accumulation of cancer risks that are modifiable through policy\, regulatory\, and behaviour changes. In this presentation I will provide an overview of my cancer prevention research program\, highlighting specific studies evaluating the interaction between people\, places\, and cancer. Attendees of this talk will gain an understanding of how the environment influences cancer risk\, and how insight into the relationship between health and place can advance cancer prevention. \nPlease contact Pamela Lee (pamela.lee@ubc.ca) for in-person or Zoom details. \n\nFILES:  C2E2 Spotlight – 011722.pdf
URL:https://scienceinvancouver.com/event/putting-cancer-in-its-place/
LOCATION:VGH Research Pavilion\, 828 West 10 Ave\, Vancouver\, BC\, V5Z 1M9\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220117T120000
DTEND;TZID=America/Vancouver:20220117T130000
DTSTAMP:20260619T101556
CREATED:20211217T222024Z
LAST-MODIFIED:20211217T222024Z
UID:26489-1642420800-1642424400@scienceinvancouver.com
SUMMARY:Putting Cancer in Its Place
DESCRIPTION:DATE: Jan 17\, 2022 – 12:00pm to 1:00pm \nLOCATION: 700-828 W. 10 Ave. VGH Research Pavilion \nPRESENTER: Trevor Dummer \nCancer prevention is central to a successful cancer control strategy. Improved knowledge about cancer risks\, and effective translation of this knowledge into action\, are essential for developing prevention activities. Place—where we live\, work and play—significantly influences the accumulation of cancer risks that are modifiable through policy\, regulatory\, and behaviour changes. In this presentation I will provide an overview of my cancer prevention research program\, highlighting specific studies evaluating the interaction between people\, places\, and cancer. Attendees of this talk will gain an understanding of how the environment influences cancer risk\, and how insight into the relationship between health and place can advance cancer prevention. \nPlease contact Pamela Lee (pamela.lee@ubc.ca) for in-person or Zoom details. \n\nFILES:  C2E2 Spotlight – 011722.pdf
URL:https://scienceinvancouver.com/event/putting-cancer-in-its-place-2/
LOCATION:VGH Research Pavilion\, 828 West 10 Ave\, Vancouver\, BC\, V5Z 1M9\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220117T120000
DTEND;TZID=America/Vancouver:20220117T130000
DTSTAMP:20260619T101556
CREATED:20211217T222024Z
LAST-MODIFIED:20211217T222024Z
UID:28104-1642420800-1642424400@scienceinvancouver.com
SUMMARY:Putting Cancer in Its Place
DESCRIPTION:DATE: Jan 17\, 2022 – 12:00pm to 1:00pm \nLOCATION: 700-828 W. 10 Ave. VGH Research Pavilion \nPRESENTER: Trevor Dummer \nCancer prevention is central to a successful cancer control strategy. Improved knowledge about cancer risks\, and effective translation of this knowledge into action\, are essential for developing prevention activities. Place—where we live\, work and play—significantly influences the accumulation of cancer risks that are modifiable through policy\, regulatory\, and behaviour changes. In this presentation I will provide an overview of my cancer prevention research program\, highlighting specific studies evaluating the interaction between people\, places\, and cancer. Attendees of this talk will gain an understanding of how the environment influences cancer risk\, and how insight into the relationship between health and place can advance cancer prevention. \nPlease contact Pamela Lee (pamela.lee@ubc.ca) for in-person or Zoom details. \n\nFILES:  C2E2 Spotlight – 011722.pdf
URL:https://scienceinvancouver.com/event/putting-cancer-in-its-place-3/
LOCATION:VGH Research Pavilion\, 828 West 10 Ave\, Vancouver\, BC\, V5Z 1M9\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220117T120000
DTEND;TZID=America/Vancouver:20220117T130000
DTSTAMP:20260619T101556
CREATED:20211217T222024Z
LAST-MODIFIED:20211217T222024Z
UID:31187-1642420800-1642424400@scienceinvancouver.com
SUMMARY:Putting Cancer in Its Place
DESCRIPTION:DATE: Jan 17\, 2022 – 12:00pm to 1:00pm \nLOCATION: 700-828 W. 10 Ave. VGH Research Pavilion \nPRESENTER: Trevor Dummer \nCancer prevention is central to a successful cancer control strategy. Improved knowledge about cancer risks\, and effective translation of this knowledge into action\, are essential for developing prevention activities. Place—where we live\, work and play—significantly influences the accumulation of cancer risks that are modifiable through policy\, regulatory\, and behaviour changes. In this presentation I will provide an overview of my cancer prevention research program\, highlighting specific studies evaluating the interaction between people\, places\, and cancer. Attendees of this talk will gain an understanding of how the environment influences cancer risk\, and how insight into the relationship between health and place can advance cancer prevention. \nPlease contact Pamela Lee (pamela.lee@ubc.ca) for in-person or Zoom details. \n\nFILES:  C2E2 Spotlight – 011722.pdf
URL:https://scienceinvancouver.com/event/putting-cancer-in-its-place-4/
LOCATION:VGH Research Pavilion\, 828 West 10 Ave\, Vancouver\, BC\, V5Z 1M9\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220112T120000
DTEND;TZID=America/Vancouver:20220112T130000
DTSTAMP:20260619T101556
CREATED:20220105T210243Z
LAST-MODIFIED:20220105T210243Z
UID:20118-1641988800-1641992400@scienceinvancouver.com
SUMMARY:Patient-Oriented Research: Why\, What\, and How?
DESCRIPTION:Join us for a panel discussion to learn about the meaning and importance of patient-oriented research. Learn how to get started in patient-oriented research and discover how patient engagement offers new and beneficial insights into health research. \nThis workshop is part of our VCHRI Research Training Series. This series is designed to support the acquisition of advanced skills\, techniques and knowledge\, and lead to enhanced practices in the conduct of research. \nLearning objectives\nIn this workshop\, you will learn: \n\nWhat patient-oriented research is\, why it is important and how you can implement it into your project\nDifferent ways to engage a patient partner in your project\nThings to consider when collaborating with a patient partner\nHow panelists are involved in patient-orientated research
URL:https://scienceinvancouver.com/event/patient-oriented-research-why-what-and-how/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Patient-Oriented-Research.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220112T120000
DTEND;TZID=America/Vancouver:20220112T130000
DTSTAMP:20260619T101556
CREATED:20220105T210243Z
LAST-MODIFIED:20220105T210243Z
UID:26493-1641988800-1641992400@scienceinvancouver.com
SUMMARY:Patient-Oriented Research: Why\, What\, and How?
DESCRIPTION:Join us for a panel discussion to learn about the meaning and importance of patient-oriented research. Learn how to get started in patient-oriented research and discover how patient engagement offers new and beneficial insights into health research. \nThis workshop is part of our VCHRI Research Training Series. This series is designed to support the acquisition of advanced skills\, techniques and knowledge\, and lead to enhanced practices in the conduct of research. \nLearning objectives\nIn this workshop\, you will learn: \n\nWhat patient-oriented research is\, why it is important and how you can implement it into your project\nDifferent ways to engage a patient partner in your project\nThings to consider when collaborating with a patient partner\nHow panelists are involved in patient-orientated research
URL:https://scienceinvancouver.com/event/patient-oriented-research-why-what-and-how-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Patient-Oriented-Research.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220112T120000
DTEND;TZID=America/Vancouver:20220112T130000
DTSTAMP:20260619T101556
CREATED:20220105T210243Z
LAST-MODIFIED:20220105T210243Z
UID:28108-1641988800-1641992400@scienceinvancouver.com
SUMMARY:Patient-Oriented Research: Why\, What\, and How?
DESCRIPTION:Join us for a panel discussion to learn about the meaning and importance of patient-oriented research. Learn how to get started in patient-oriented research and discover how patient engagement offers new and beneficial insights into health research. \nThis workshop is part of our VCHRI Research Training Series. This series is designed to support the acquisition of advanced skills\, techniques and knowledge\, and lead to enhanced practices in the conduct of research. \nLearning objectives\nIn this workshop\, you will learn: \n\nWhat patient-oriented research is\, why it is important and how you can implement it into your project\nDifferent ways to engage a patient partner in your project\nThings to consider when collaborating with a patient partner\nHow panelists are involved in patient-orientated research
URL:https://scienceinvancouver.com/event/patient-oriented-research-why-what-and-how-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Patient-Oriented-Research.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220112T120000
DTEND;TZID=America/Vancouver:20220112T130000
DTSTAMP:20260619T101556
CREATED:20220105T210243Z
LAST-MODIFIED:20220105T210243Z
UID:31191-1641988800-1641992400@scienceinvancouver.com
SUMMARY:Patient-Oriented Research: Why\, What\, and How?
DESCRIPTION:Join us for a panel discussion to learn about the meaning and importance of patient-oriented research. Learn how to get started in patient-oriented research and discover how patient engagement offers new and beneficial insights into health research. \nThis workshop is part of our VCHRI Research Training Series. This series is designed to support the acquisition of advanced skills\, techniques and knowledge\, and lead to enhanced practices in the conduct of research. \nLearning objectives\nIn this workshop\, you will learn: \n\nWhat patient-oriented research is\, why it is important and how you can implement it into your project\nDifferent ways to engage a patient partner in your project\nThings to consider when collaborating with a patient partner\nHow panelists are involved in patient-orientated research
URL:https://scienceinvancouver.com/event/patient-oriented-research-why-what-and-how-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Patient-Oriented-Research.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220112T120000
DTEND;TZID=America/Vancouver:20220112T130000
DTSTAMP:20260619T101556
CREATED:20220105T210243Z
LAST-MODIFIED:20220105T210243Z
UID:32651-1641988800-1641992400@scienceinvancouver.com
SUMMARY:Patient-Oriented Research: Why\, What\, and How?
DESCRIPTION:Join us for a panel discussion to learn about the meaning and importance of patient-oriented research. Learn how to get started in patient-oriented research and discover how patient engagement offers new and beneficial insights into health research. \nThis workshop is part of our VCHRI Research Training Series. This series is designed to support the acquisition of advanced skills\, techniques and knowledge\, and lead to enhanced practices in the conduct of research. \nLearning objectives\nIn this workshop\, you will learn: \n\nWhat patient-oriented research is\, why it is important and how you can implement it into your project\nDifferent ways to engage a patient partner in your project\nThings to consider when collaborating with a patient partner\nHow panelists are involved in patient-orientated research
URL:https://scienceinvancouver.com/event/patient-oriented-research-why-what-and-how-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Patient-Oriented-Research.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220112T100000
DTEND;TZID=America/Vancouver:20220112T110000
DTSTAMP:20260619T101556
CREATED:20211217T215312Z
LAST-MODIFIED:20211217T215312Z
UID:32644-1641981600-1641985200@scienceinvancouver.com
SUMMARY:MSL Seminar Series: January – Invited Speaker\, Dr. Jilie Chai
DESCRIPTION:Invited Speaker: Dr. Jilie Chai\, MPI Germany \nTalk title: Biochemical functions of plant NLRs \nNucleotide binding and leucine-rich repeat containing receptors (NLRs) play a critical role in innate immunity of both animals and plants. Plant NLRs mediate specific recognition of pathogen effector proteins delivered into cells\, initiating effector-triggered immunity (ETI). Significant progress has been made in our understanding of ETI signaling mechanism during the past three years. Recognition of pathogen effectors results in assembly of oligomeric NLRs\, forming large protein complexes termed resistosomes that act as either cation channels or NADase holoenzymes to initiate ETI signaling. I will present what we have done about reconstitution of NLR resistosomes and structural and biochemical characterization of these large protein complexes. I will also present some unpublished data concerning a new biochemical activity (2´\,3´-cAMP/cGMP synthetase actvity) of plant TIR-containing. \nHost: Dr. Xin Li
URL:https://scienceinvancouver.com/event/msl-seminar-series-january-invited-speaker-dr-jilie-chai-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220112T100000
DTEND;TZID=America/Vancouver:20220112T110000
DTSTAMP:20260619T101556
CREATED:20211217T215312Z
LAST-MODIFIED:20211217T215312Z
UID:19891-1641981600-1641985200@scienceinvancouver.com
SUMMARY:MSL Seminar Series: January – Invited Speaker\, Dr. Jilie Chai
DESCRIPTION:Invited Speaker: Dr. Jilie Chai\, MPI Germany \nTalk title: Biochemical functions of plant NLRs \nNucleotide binding and leucine-rich repeat containing receptors (NLRs) play a critical role in innate immunity of both animals and plants. Plant NLRs mediate specific recognition of pathogen effector proteins delivered into cells\, initiating effector-triggered immunity (ETI). Significant progress has been made in our understanding of ETI signaling mechanism during the past three years. Recognition of pathogen effectors results in assembly of oligomeric NLRs\, forming large protein complexes termed resistosomes that act as either cation channels or NADase holoenzymes to initiate ETI signaling. I will present what we have done about reconstitution of NLR resistosomes and structural and biochemical characterization of these large protein complexes. I will also present some unpublished data concerning a new biochemical activity (2´\,3´-cAMP/cGMP synthetase actvity) of plant TIR-containing. \nHost: Dr. Xin Li
URL:https://scienceinvancouver.com/event/msl-seminar-series-january-invited-speaker-dr-jilie-chai/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220112T100000
DTEND;TZID=America/Vancouver:20220112T110000
DTSTAMP:20260619T101556
CREATED:20211217T215312Z
LAST-MODIFIED:20211217T215312Z
UID:26486-1641981600-1641985200@scienceinvancouver.com
SUMMARY:MSL Seminar Series: January – Invited Speaker\, Dr. Jilie Chai
DESCRIPTION:Invited Speaker: Dr. Jilie Chai\, MPI Germany \nTalk title: Biochemical functions of plant NLRs \nNucleotide binding and leucine-rich repeat containing receptors (NLRs) play a critical role in innate immunity of both animals and plants. Plant NLRs mediate specific recognition of pathogen effector proteins delivered into cells\, initiating effector-triggered immunity (ETI). Significant progress has been made in our understanding of ETI signaling mechanism during the past three years. Recognition of pathogen effectors results in assembly of oligomeric NLRs\, forming large protein complexes termed resistosomes that act as either cation channels or NADase holoenzymes to initiate ETI signaling. I will present what we have done about reconstitution of NLR resistosomes and structural and biochemical characterization of these large protein complexes. I will also present some unpublished data concerning a new biochemical activity (2´\,3´-cAMP/cGMP synthetase actvity) of plant TIR-containing. \nHost: Dr. Xin Li
URL:https://scienceinvancouver.com/event/msl-seminar-series-january-invited-speaker-dr-jilie-chai-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220112T100000
DTEND;TZID=America/Vancouver:20220112T110000
DTSTAMP:20260619T101556
CREATED:20211217T215312Z
LAST-MODIFIED:20211217T215312Z
UID:28101-1641981600-1641985200@scienceinvancouver.com
SUMMARY:MSL Seminar Series: January – Invited Speaker\, Dr. Jilie Chai
DESCRIPTION:Invited Speaker: Dr. Jilie Chai\, MPI Germany \nTalk title: Biochemical functions of plant NLRs \nNucleotide binding and leucine-rich repeat containing receptors (NLRs) play a critical role in innate immunity of both animals and plants. Plant NLRs mediate specific recognition of pathogen effector proteins delivered into cells\, initiating effector-triggered immunity (ETI). Significant progress has been made in our understanding of ETI signaling mechanism during the past three years. Recognition of pathogen effectors results in assembly of oligomeric NLRs\, forming large protein complexes termed resistosomes that act as either cation channels or NADase holoenzymes to initiate ETI signaling. I will present what we have done about reconstitution of NLR resistosomes and structural and biochemical characterization of these large protein complexes. I will also present some unpublished data concerning a new biochemical activity (2´\,3´-cAMP/cGMP synthetase actvity) of plant TIR-containing. \nHost: Dr. Xin Li
URL:https://scienceinvancouver.com/event/msl-seminar-series-january-invited-speaker-dr-jilie-chai-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220112T100000
DTEND;TZID=America/Vancouver:20220112T110000
DTSTAMP:20260619T101556
CREATED:20211217T215312Z
LAST-MODIFIED:20211217T215312Z
UID:31184-1641981600-1641985200@scienceinvancouver.com
SUMMARY:MSL Seminar Series: January – Invited Speaker\, Dr. Jilie Chai
DESCRIPTION:Invited Speaker: Dr. Jilie Chai\, MPI Germany \nTalk title: Biochemical functions of plant NLRs \nNucleotide binding and leucine-rich repeat containing receptors (NLRs) play a critical role in innate immunity of both animals and plants. Plant NLRs mediate specific recognition of pathogen effector proteins delivered into cells\, initiating effector-triggered immunity (ETI). Significant progress has been made in our understanding of ETI signaling mechanism during the past three years. Recognition of pathogen effectors results in assembly of oligomeric NLRs\, forming large protein complexes termed resistosomes that act as either cation channels or NADase holoenzymes to initiate ETI signaling. I will present what we have done about reconstitution of NLR resistosomes and structural and biochemical characterization of these large protein complexes. I will also present some unpublished data concerning a new biochemical activity (2´\,3´-cAMP/cGMP synthetase actvity) of plant TIR-containing. \nHost: Dr. Xin Li
URL:https://scienceinvancouver.com/event/msl-seminar-series-january-invited-speaker-dr-jilie-chai-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220111T100000
DTEND;TZID=America/Vancouver:20220111T110000
DTSTAMP:20260619T101556
CREATED:20211217T223227Z
LAST-MODIFIED:20211217T223227Z
UID:19916-1641895200-1641898800@scienceinvancouver.com
SUMMARY:Gairdner Webinar: Gut Peptides Drive Therapeutic Innovation
DESCRIPTION:Introduction and Q&A Moderator:\n\nDr. Janet Rossant\, President & Scientific Director\, The Gairdner Foundation\n\nSpeaker:\n\nDr. Daniel Drucker\, Professor of Medicine – Department of Medicine\, University of Toronto; Senior Scientist\, Lunenfeld-Tanenbaum Research Institute\, Mt. Sinai Hospital\n\n \nThe Gairdner Foundation is pleased to partner with Life Sciences BC again for a virtual event on January 11 at 10 am PST. The Gairdner Foundation celebrates and recognizes scientific excellence through the Canada Gairdner Awards. Dr. Daniel Drucker received the 2021 Canada Gairdner International Award along with Dr. Jens Holst and Dr. Joel Habener for their research on glucagon-like peptides that has led to major advances in the treatment of Type 2 diabetes\, obesity and intestinal disorders. His lecture is called “Gut peptides drive therapeutic innovation for people with metabolic disorders.” \nPresentation – “Gut peptides drive therapeutic innovation for people with metabolic disorders”.
URL:https://scienceinvancouver.com/event/gairdner-webinar-gut-peptides-drive-therapeutic-innovation/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Gairdner-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220111T100000
DTEND;TZID=America/Vancouver:20220111T110000
DTSTAMP:20260619T101556
CREATED:20211217T223227Z
LAST-MODIFIED:20211217T223227Z
UID:26491-1641895200-1641898800@scienceinvancouver.com
SUMMARY:Gairdner Webinar: Gut Peptides Drive Therapeutic Innovation
DESCRIPTION:Introduction and Q&A Moderator:\n\nDr. Janet Rossant\, President & Scientific Director\, The Gairdner Foundation\n\nSpeaker:\n\nDr. Daniel Drucker\, Professor of Medicine – Department of Medicine\, University of Toronto; Senior Scientist\, Lunenfeld-Tanenbaum Research Institute\, Mt. Sinai Hospital\n\n \nThe Gairdner Foundation is pleased to partner with Life Sciences BC again for a virtual event on January 11 at 10 am PST. The Gairdner Foundation celebrates and recognizes scientific excellence through the Canada Gairdner Awards. Dr. Daniel Drucker received the 2021 Canada Gairdner International Award along with Dr. Jens Holst and Dr. Joel Habener for their research on glucagon-like peptides that has led to major advances in the treatment of Type 2 diabetes\, obesity and intestinal disorders. His lecture is called “Gut peptides drive therapeutic innovation for people with metabolic disorders.” \nPresentation – “Gut peptides drive therapeutic innovation for people with metabolic disorders”.
URL:https://scienceinvancouver.com/event/gairdner-webinar-gut-peptides-drive-therapeutic-innovation-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Gairdner-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220111T100000
DTEND;TZID=America/Vancouver:20220111T110000
DTSTAMP:20260619T101556
CREATED:20211217T223227Z
LAST-MODIFIED:20211217T223227Z
UID:28106-1641895200-1641898800@scienceinvancouver.com
SUMMARY:Gairdner Webinar: Gut Peptides Drive Therapeutic Innovation
DESCRIPTION:Introduction and Q&A Moderator:\n\nDr. Janet Rossant\, President & Scientific Director\, The Gairdner Foundation\n\nSpeaker:\n\nDr. Daniel Drucker\, Professor of Medicine – Department of Medicine\, University of Toronto; Senior Scientist\, Lunenfeld-Tanenbaum Research Institute\, Mt. Sinai Hospital\n\n \nThe Gairdner Foundation is pleased to partner with Life Sciences BC again for a virtual event on January 11 at 10 am PST. The Gairdner Foundation celebrates and recognizes scientific excellence through the Canada Gairdner Awards. Dr. Daniel Drucker received the 2021 Canada Gairdner International Award along with Dr. Jens Holst and Dr. Joel Habener for their research on glucagon-like peptides that has led to major advances in the treatment of Type 2 diabetes\, obesity and intestinal disorders. His lecture is called “Gut peptides drive therapeutic innovation for people with metabolic disorders.” \nPresentation – “Gut peptides drive therapeutic innovation for people with metabolic disorders”.
URL:https://scienceinvancouver.com/event/gairdner-webinar-gut-peptides-drive-therapeutic-innovation-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Gairdner-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220111T100000
DTEND;TZID=America/Vancouver:20220111T110000
DTSTAMP:20260619T101556
CREATED:20211217T223227Z
LAST-MODIFIED:20211217T223227Z
UID:31189-1641895200-1641898800@scienceinvancouver.com
SUMMARY:Gairdner Webinar: Gut Peptides Drive Therapeutic Innovation
DESCRIPTION:Introduction and Q&A Moderator:\n\nDr. Janet Rossant\, President & Scientific Director\, The Gairdner Foundation\n\nSpeaker:\n\nDr. Daniel Drucker\, Professor of Medicine – Department of Medicine\, University of Toronto; Senior Scientist\, Lunenfeld-Tanenbaum Research Institute\, Mt. Sinai Hospital\n\n \nThe Gairdner Foundation is pleased to partner with Life Sciences BC again for a virtual event on January 11 at 10 am PST. The Gairdner Foundation celebrates and recognizes scientific excellence through the Canada Gairdner Awards. Dr. Daniel Drucker received the 2021 Canada Gairdner International Award along with Dr. Jens Holst and Dr. Joel Habener for their research on glucagon-like peptides that has led to major advances in the treatment of Type 2 diabetes\, obesity and intestinal disorders. His lecture is called “Gut peptides drive therapeutic innovation for people with metabolic disorders.” \nPresentation – “Gut peptides drive therapeutic innovation for people with metabolic disorders”.
URL:https://scienceinvancouver.com/event/gairdner-webinar-gut-peptides-drive-therapeutic-innovation-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Gairdner-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220111T100000
DTEND;TZID=America/Vancouver:20220111T110000
DTSTAMP:20260619T101556
CREATED:20211217T223227Z
LAST-MODIFIED:20211217T223227Z
UID:32649-1641895200-1641898800@scienceinvancouver.com
SUMMARY:Gairdner Webinar: Gut Peptides Drive Therapeutic Innovation
DESCRIPTION:Introduction and Q&A Moderator:\n\nDr. Janet Rossant\, President & Scientific Director\, The Gairdner Foundation\n\nSpeaker:\n\nDr. Daniel Drucker\, Professor of Medicine – Department of Medicine\, University of Toronto; Senior Scientist\, Lunenfeld-Tanenbaum Research Institute\, Mt. Sinai Hospital\n\n \nThe Gairdner Foundation is pleased to partner with Life Sciences BC again for a virtual event on January 11 at 10 am PST. The Gairdner Foundation celebrates and recognizes scientific excellence through the Canada Gairdner Awards. Dr. Daniel Drucker received the 2021 Canada Gairdner International Award along with Dr. Jens Holst and Dr. Joel Habener for their research on glucagon-like peptides that has led to major advances in the treatment of Type 2 diabetes\, obesity and intestinal disorders. His lecture is called “Gut peptides drive therapeutic innovation for people with metabolic disorders.” \nPresentation – “Gut peptides drive therapeutic innovation for people with metabolic disorders”.
URL:https://scienceinvancouver.com/event/gairdner-webinar-gut-peptides-drive-therapeutic-innovation-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Gairdner-Webinar.png
END:VEVENT
END:VCALENDAR